Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study
Maturity-onset diabetes of the young (MODY) is a grouping of monogenic disorders. It is characterized by dominantly inherited, non-insulin-dependent diabetes. MODY is relatively rare, encompassing up to 3.5% in those diagnosed under 30 years of age. Specific types are most commonly treated with sulf...
| Hauptverfasser: | , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Frontiers Media S.A.
2024-03-01
|
| Schriftenreihe: | Frontiers in Endocrinology |
| Schlagworte: | |
| Online Zugang: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1294264/full |